Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 25–36 of 124 articles · Check methods and identity
- Check methods and identity
What a 2026 GHRP-2 study measured in the adrenal system
Growth hormone–releasing peptide 2, or GHRP-2, is a synthetic six-residue agonist of the ghrelin receptor. It is also called pralmorelin. A September 2026 study asked whether the cortisol response to a GHRP-2 challenge could help identify where a problem in the adrenal signaling pathway began.
GHRP-22 sources (2025, 2026)
- Check methods and identity
Measuring a meal response in participants of different body sizes
Growth hormone–releasing peptide 2 (GHRP-2) is a synthetic six-amino-acid peptide that acts on the ghrelin receptor. Does the effect observed at a meal differ between people with and without obesity? No recent primary trial testing this specific meal question was identified.
GHRP-22 sources (2006, 2025)
- Check methods and identity
What a rat stroke experiment measured in tissue near the injury
GHRP-6 is a six-residue synthetic growth hormone secretagogue and ghrelin-receptor agonist. A 2026 animal study examined the proteins that changed after GHRP-6 and epidermal growth factor (EGF) were given together in a stroke model.
GHRP-63 sources (2021, 2026)
- Check methods and identity
Why the GLOW Name Does Not Identify a Single Peptide
GLOW is a catalog name for a blend, rather than the name of one defined peptide. The formulation discussed here refers to three named components: GHK-Cu, BPC-157 and material labeled TB-500.
GLOW Blend3 sources (2026)
- Check methods and identity
Why Adding MOTS c Changes the Question Behind the GLOW 2 Label
GLOW 2 is a catalog name for a mixture. The formulation described in the supplied catalog names GHK-Cu, BPC-157 and MOTS-c, although the exact supplier formulation is unconfirmed. This account uses those names to discuss the research questions they raise.
GLOW 2 Blend2 sources (2026)
- Check methods and identity
What Measuring Naturally Occurring MOTS c Can Tell Us
MOTS-c is a mitochondrial peptide named in the catalog description of GLOW 2. Studying naturally occurring MOTS-c in people's blood or tissue asks a different question from studying a mixture given to a person. A 2026 study of polycystic ovary syndrome illustrates the difference.
GLOW 2 Blend1 source (2026)
- Check methods and identity
Why Oxygen Measurements in Wounds Differ From Muscle Energy Measurements
GLOW 2 is a catalog blend name linked to GHK-Cu, BPC-157 and MOTS-c. Research on two of those names sometimes uses similar words, such as oxygen, oxidative stress or energy. A closer look at the experiments shows that those words refer to different measurements.
GLOW 2 Blend2 sources (2026)
- Check methods and identity
Why an alcohol study measured craving and drinking separately
Semaglutide is a GLP-1 receptor agonist with approved uses for specified metabolic and cardiovascular indications, depending on the product. In a 2026 trial, researchers investigated a different question.
GLP-1 SEMA2 sources (2026)
- Check methods and identity
What a noninvasive liver score measured in the SAMARA trial
Semaglutide is a modified peptide that activates the GLP-1 receptor. The SAMARA study, published in 2026, asked whether noninvasive tests could detect a change in adults with suspected at-risk metabolic dysfunction-associated steatohepatitis, or MASH, who were assigned to semaglutide or placebo.
GLP-1 SEMA2 sources (2026)
- Check methods and identity
What an antibody add-on study measured besides weight
Tirzepatide is a peptide that activates GIP and GLP-1 receptors. The “GLP-2” wording in the catalog label does not correspond to a receptor target.
GLP-2 TIRZ2 sources (2022, 2026)
- Check methods and identity
How SURMOUNT-MAINTAIN tested weight maintenance
Tirzepatide activates GIP and GLP-1 receptors. In “GLP-2 TIRZ,” the GLP-2 wording is a catalog identifier. The SURMOUNT-MAINTAIN trial examined what happened to body weight after adults had already taken tirzepatide during an initial weight-loss phase.
GLP-2 TIRZ2 sources (2022, 2026)
- Check methods and identity
What the October 2026 recall tells us about product quality
Glutathione is a naturally occurring peptide made of three amino acids that participates in those protective reactions. A recall posted by the FDA in October 2026 concerned a different question, whether certain compounded glutathione products met a safety standard for bacterial endotoxins.
Glutathione2 sources (2019, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
